# Justin A. Ezekowitz

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/justin-a-ezekowitz/

## Facts

| Field | Value |
| --- | --- |
| Citations | 55,805 |
| Field | Heart Failure Treatment and Management |
| h-index | 88 |
| i10-index | 367 |
| Last Known Institution | University of Alberta |
| OpenAlex ID | https://openalex.org/A5006527198 |
| ORCID iD | https://orcid.org/0000-0002-2724-4086 |
| Works | 1,051 |

## Researcher papers

Showing 12 of 13.

- [2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure](https://scholariq.org/papers/2021-esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-chronic-heart/)
- [Apixaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/apixaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/vericiguat-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [Effect of Nesiritide in Patients with Acute Decompensated Heart Failure](https://scholariq.org/papers/effect-of-nesiritide-in-patients-with-acute-decompensated-heart-failure/)
- [2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure](https://scholariq.org/papers/2017-comprehensive-update-of-the-canadian-cardiovascular-society-guidelines-for/)
- [Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes](https://scholariq.org/papers/semaglutide-in-patients-with-obesity-related-heart-failure-and-type-2-diabetes/)
- [Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction](https://scholariq.org/papers/cardiac-resynchronization-therapy-for-patients-with-left-ventricular-systolic/)
- [Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial](https://scholariq.org/papers/chronic-oral-study-of-myosin-activation-to-increase-contractility-in-heart/)
- [Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function](https://scholariq.org/papers/ethnic-specific-normative-reference-values-for-echocardiographic-la-and-lv-size/)
- [Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial](https://scholariq.org/papers/patiromer-for-the-management-of-hyperkalemia-in-heart-failure-with-reduced/)
- [The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure](https://scholariq.org/papers/the-2012-canadian-cardiovascular-society-heart-failure-management-guidelines/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)

## Researcher university

- [University of Alberta](https://scholariq.org/institutions/university-of-alberta/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.